|
Primary myelofibrosis Health Article
|
| Table of Contents |
Definition
Primary myelofibrosis is a disorder of the bone marrow, in which the marrow is replaced by fibrous (scar) tissue.
Alternative Names
Myelofibrosis; Idiopathic myelofibrosis; Myeloid metaplasia; Agnogenic myeloid metaplasia
Causes, incidence, and risk factors
The cause of primary myelofibrosis is unknown. Scarring of the bone marrow causes blood to form in abnormal sites, such as the liver and spleen. This causes swelling of these organs. There are no known risk factors. The disorder usually develops slowly in people over age 50.
Symptoms
Signs and tests
Physical examination shows spleen swelling. Later in the disease, it may also show an enlarged liver. Tests that may be done include:
An examination of the blood shows teardrop-shaped red blood cells. Bone marrow biopsy may be done to rule out other causes of the symptoms.
Treatment
There is no specific treatment for primary myelofibrosis. The goal of treatment is to relieve symptoms. Treatment may involve:
In young people, bone marrow transplants appear to improve the outlook.
Expectations (prognosis)
This disorder causes slowly worsening bone marrow failure with severe anemia. Low platelet count leads to easy bleeding, and spleen swelling may slowly get worse. The average survival of people with primary myelofibrosis is about 5 years. However, many people survive for decades.
Complications
Calling your health care provider
Call for an appointment with your health care provider if symptoms of this disorder develop. Uncontrolled bleeding, shortness of breath, jaundice, and confusion that gets worse require urgent or emergency care.
Prevention
There is no known prevention. |
advertisement |
|
Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.